Skip to end of metadata
Go to start of metadata

The NIH Women Scientist Advisors (WSA) was established in 1992 as an open forum for women scientists in the NIH Intramural Research Program (IRP) to discuss and exchange ideas. CCR’s WSA are elected by their colleagues and serve two-year terms.

The CCR WSAs support and promote career development and address issues that women scientists may face.  Their activities include:

  • Sponsor the annual NCI Rosalind E. Franklin Award Lecture for Women in Cancer Research held at the intramural PI retreat and other lectures throughout the year of interest to the community;
  • Hold “Brown Bag” informal open meetings to update CCR women scientists and hear about their concerns;
  • Attend CCR Lab/Branch Chief meetings as WSA representative;
  • Meet on a regular basis with the CCR Scientific Directors to discuss activities and issues of interest to the women scientist community;
  • Represent CCR at NIH WSA meetings and activities;
  • Provide career development advice and/or resources to CCR women scientists.


(L to R) Pat Steeg, Carol Thiele, Mary Kearney, Terry Armstrong, Nirali Shah, Brunilde Gril (not pictured)

CCR Women Scientific Advisors
Carol J. Thiele, Ph.D. - Pediatric Oncology Branch (Bethesda Campus - Term ends 2020)
Patricia S. Steeg, Ph.D. - Women's Malignancies Branch (Bethesda Campus - Term ends 2020)Terri Armstrong, Ph.D. - Neuro Oncology Branch (Bethesda Campus - Term ends 2022)
Mary Kearney, Ph.D. - Host - Virus Interaction Branch (Frederick Campus - Term ends 2022)

Adjunct WSAs
Brunilde Gril, Ph.D.- Women's Malignancies Branch , (Staff Scientists)
Nirali Shah, M.D. 
- Pediatric Oncology Branch, (Staff Clinicians)

CCR OD Liaison
Beverly Mock, Ph.D. - CCR Deputy Director
Laura Hooper, Ph.D.
- Scientific Program Analyst

Special Notices/Announcements

 Upcoming Events

WSA Meet and Greet



Seminar Series: Women Leaders in Biotech and Pharma

March 28 - Bldg. 37 room 2041/2107, 1-2pm, in Bethesda (with VTC to Bldg. 549 Auditorium, Frederick)
Sabina Cosulich, Ph.D.
Director, Oncology Research
AstraZeneca
 
April 25 - Bldg. 37 room 2041/2107, 1-2pm, in Bethesda (with VTC to Bldg. 549 Auditorium, Frederick)
Kristen M. Hege, M.D.
VP Translational Development
Celgene
 
June 6 - Bldg. 549 Auditorium, 1-2pm, in Frederick (with VTC to Bldg. 37 room 2041/2107, Bethesda)
Payel Sheth, Ph.D.
Executive Director, Mass Spectrometry & Biophysics
Merck Research Laboratories

For questions, please contact Laura Hooper at hooperl@mail.nih.gov


 

 

 

Last updated by Sawhney, Romi (NIH/NCI) [E] on Feb 05, 2019